Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert Samstein(Memorial Sloan Kettering Cancer Center), Chung‐Han Lee(Memorial Sloan Kettering Cancer Center), Alexander N. Shoushtari(Memorial Sloan Kettering Cancer Center), Matthew D. Hellmann(Memorial Sloan Kettering Cancer Center), Ronglai Shen(Memorial Sloan Kettering Cancer Center), Yelena Y. Janjigian(Memorial Sloan Kettering Cancer Center), David Barron(Memorial Sloan Kettering Cancer Center), Ahmet Zehir(Memorial Sloan Kettering Cancer Center), Emmet Jordan(Memorial Sloan Kettering Cancer Center), Antonio Omuro(Memorial Sloan Kettering Cancer Center), Thomas Kaley(Memorial Sloan Kettering Cancer Center), Sviatoslav M. Kendall(Memorial Sloan Kettering Cancer Center), Robert J. Motzer(Memorial Sloan Kettering Cancer Center), A. Ari Hakimi(Memorial Sloan Kettering Cancer Center), Martin H. Voss(Memorial Sloan Kettering Cancer Center), Paul Russo(Memorial Sloan Kettering Cancer Center), Jonathan E. Rosenberg(Memorial Sloan Kettering Cancer Center), Gopa Iyer(Memorial Sloan Kettering Cancer Center), Bernard H. Bochner(Memorial Sloan Kettering Cancer Center), Dean F. Bajorin(Memorial Sloan Kettering Cancer Center), Hikmat Al‐Ahmadie(Memorial Sloan Kettering Cancer Center), Jamie E. Chaft(Memorial Sloan Kettering Cancer Center), Charles M. Rudin(Memorial Sloan Kettering Cancer Center), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Shrujal S. Baxi(Memorial Sloan Kettering Cancer Center), Alan L. Ho(Memorial Sloan Kettering Cancer Center), Richard J. Wong(Memorial Sloan Kettering Cancer Center), David G. Pfister(Memorial Sloan Kettering Cancer Center), Jedd D. Wolchok(Memorial Sloan Kettering Cancer Center), Christopher A. Barker(Memorial Sloan Kettering Cancer Center), Philip H. Gutin(Memorial Sloan Kettering Cancer Center), Cameron Brennan(Memorial Sloan Kettering Cancer Center), Viviane Tabar(Memorial Sloan Kettering Cancer Center), Ingo K. Mellinghoff(Memorial Sloan Kettering Cancer Center), Lisa M. DeAngelis(Memorial Sloan Kettering Cancer Center), Charlotte E. Ariyan(Memorial Sloan Kettering Cancer Center), Nancy Y. Lee(Memorial Sloan Kettering Cancer Center), William D. Tap(Memorial Sloan Kettering Cancer Center), Mrinal M. Gounder(Memorial Sloan Kettering Cancer Center), Sandra P. D’Angelo(Cornell University), Leonard B. Saltz(Memorial Sloan Kettering Cancer Center), Zsofia K. Stadler(Memorial Sloan Kettering Cancer Center), Howard I. Scher(Memorial Sloan Kettering Cancer Center), José Baselga(Memorial Sloan Kettering Cancer Center), Pedram Razavi(Memorial Sloan Kettering Cancer Center), Christopher A. Klebanoff(Memorial Sloan Kettering Cancer Center), Rona Yaeger(Memorial Sloan Kettering Cancer Center), Neil H. Segal(Memorial Sloan Kettering Cancer Center), Geoffrey Y. Ku(Memorial Sloan Kettering Cancer Center), Ronald P. DeMatteo(Memorial Sloan Kettering Cancer Center), Marc Ladanyi(Memorial Sloan Kettering Cancer Center), Naiyer A. Rizvi(Columbia University Irving Medical Center), Michael F. Berger(Memorial Sloan Kettering Cancer Center), Nadeem Riaz(Memorial Sloan Kettering Cancer Center), David B. Solit(Memorial Sloan Kettering Cancer Center), Timothy A. Chan(Memorial Sloan Kettering Cancer Center), Luc G.T. Morris(Memorial Sloan Kettering Cancer Center)
Cited by 4,343Open Access
Abstract
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al.|New England Journal of Medicine|2012|12.6k
Signatures of mutational processes in human cancer
Australian Pancreatic Cancer Genome Initiative, Ludmil B. Alexandrov, ICGC PedBrain et al.|Nature|2013|10.1k